Lacticaseibacillus casei DN-114001
Lacticaseibacillus casei DN-114001 is a lactic acid bacterium studied in human and animal models in relation to immunomodulation. Research has examined the strain in relation to intestinal immunity and systemic inflammatory markers, with randomized controlled trials examining associations with infections and intestinal health. In vitro studies have examined mechanisms related to immune cell signaling, though clinical efficacy for most purported applications requires additional investigation. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 20 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 13 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+2 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
27 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 25400470 →Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea· World Journal of Gastroenterology · 2014
-
[2]
PMID 25365320 →The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis· PLoS ONE · 2014
-
[3]
PMID 16913215 →[Effect of Lactobacillus casei on the incidence of infectious conditions in children].· PubMed · 2006
-
[4]
Source →Efecto de Lactobacillus casei sobre la incidencia de procesos infecciosos en niños/as Effect of lactobacillus casei on the incidence of infectious conditions in children· DOAJ (DOAJ: Directory of Open Access Journals) · 2006
-
[5]
Source →P0900 SUPPLEMENTS OF ONE WEEK TRIPLE DRUG THERAPY WITH SPECIAL PROBIOTIC LACTOBACILLUS CASEI IMUNITASS (STRAIN DN‐114 000) AND STREPTOCOCCUS THERMOPHILUS AND LACTOBACILLUS BULGARICUS IN THE ERADICATION OF H.PYLORI‐COLONIZED CHILDREN: A PROSPECTIVE RANDOMISED TR· Journal of Pediatric Gastroenterology and Nutrition · 2004
-
[6]
PMID 12679825 →Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study.· PubMed · 2003